Cost analysis and health-related quality of life of home and self-care satellite haemodialysis

Nephrology Dialysis Transplantation

Volumn 23, Issue 6, 2008, Pages 1990-1996

  Malmström, Raija K ^a,d   Roine, Risto P ^b   Heikkilä, Anne ^b   Räsänen, Pirjo ^b   Sintonen, Harri ^b   Muroma Karttunen, Riitta ^c   Honkanen, Eero ^c  

^a Porvoo Hospital   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d NONE   (Finland)

Author keywords

Costs; Dialysis; Health related quality of life; Home haemodialysis; Satellite haemodialysis

Indexed keywords

IRON; LOW MOLECULAR WEIGHT HEPARIN; VITAMIN D;

ADULT; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; FEMALE; HEALTH CARE COST; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SELF CARE; STATISTICAL SIGNIFICANCE;

ADULT; AGE FACTORS; AGED; CHI-SQUARE DISTRIBUTION; COST OF ILLNESS; COST-BENEFIT ANALYSIS; EVALUATION STUDIES AS TOPIC; FEMALE; FINLAND; HEALTH SERVICES ACCESSIBILITY; HEMODIALYSIS, HOME; HOSPITALS, SATELLITE; HUMANS; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROBABILITY; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; SELF CARE; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 44449100225     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm910     Document Type: Article

References (21)

1. Collins AJ, Kasiske B, Herzog C et al. Excerpts from the United States renal data system 2003 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 2003; 42(Suppl 5): A5-A7
2. Honkanen E, Muroma-Karttunen R, Taponen RM et al. Starting a home hemodialysis program: single center experiences. Scand J Urol Nephrol 2002; 36: 137-144
3. Salonen T, Reina T, Oksa H et al. Cost analysis of renal replacement therapies in Finland. Am J Kidney Dis 2003; 42: 1228-1238
4. Mowatt G, Vale L, Perez J et al. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. Health Technol Assess 2003; 7: 1-174
5. Arkouche W, Traeger J, Delawari E et al. Twenty-five years of experience with out-center hemodialysis. Kidney Int 1999; 56: 2269-2275
6. Roderick P, Armitage A, Nicholson T et al. A clinical and cost evaluation of hemodialysis in renal satellite units in England and Wales. Am J Kidney Dis 2004; 44: 121-131
7. Sintonen H. Outcome measurement in acid-related diseases. Pharmacoeconomics 1994; 5(Suppl.3): 17-26
8. Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med 2001; 33: 328-336
9. Stavem K. Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease. Qual Life Res 1999; 8: 45-54
10. Hawthorne G, Richardson J, Day NA. A comparison of the assessment of quality of life (AQoL) with four other generic utility instruments. Ann Med 2001; 33: 358-370
11. Yildrim A, Ogutmen B, Bektas G et al. Translation, cultural adaptation, initial reliability, and validation of the Kidney Disease and Quality of Life-Short Form (KDQOL-SF 1.3) in Turkey. 1. Transplant Proc 2007; 39: 514
12. Aromaa A, Koskinen S. Health and functional capacity in Finland. Baseline results of the health 2000 health examination survey. Publications of National Public Health Institute, 2004; Vol. Series B 12/2004, 171
13. de Wit GA, Ramsteijn PG, de Charro FT. Economic evaluation of end stage renal disease treatment. Health Policy 1998; 44: 215-232
14. Goeree R, Manalich J, Grootendorst P et al. Cost analysis of dialysis treatments for end-stage renal disease (ESRD). Clin Invest Med 1995; 18: 455-461
15. Peeters P, Rublee D, Just PM et al. Analysis and interpretation of cost data in dialysis: review of Western European literature. Health Policy 2000; 54: 209-227
16. De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies - an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 1999; 14 (Suppl 6): 31-41
17. Loghman-Adham M. Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation. Am J Manag Care 2003; 9: 155-171
18. Bremer BA, McCauley CR, Wrona RM et al. Quality of life in end-stage renal disease: a reexamination. Am J Kidney Dis 1989; 13: 200-220
19. Piccoli GB, Mezza E, Burdese M et al. Dialysis choice in the context of an early referral policy: there is room for self care. J Nephrol 2005; 18: 267-275
20. Goovaerts T, Jadoul M, Goffin E. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy. Nephrol Dial Transplant 2005; 20: 1842-1847
21. McLaughlin K, Manns B, Mortis G et al. Why patients with ESRD do not select self-care dialysis as a treatment option. Am J Kidney Dis 2003; 41: 380-385